Avenue 81, Inc. – Trademark Portfolio
Entity Type: 03
Avenue 81, Inc. holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 32 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 9 trademarks are registered and 2 are pending. Notable registered marks include DRIP, LEADBOXES, LEADPAGES, and C CONVERTED. The owner is based in Minneapolis, MN.
251 N 1st Avenue, Suite 200
Minneapolis, MN 55401
Showing of trademarks Trademarks
Trademark Classifications
Avenue 81, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Avenue 81, Inc. have?
Avenue 81, Inc. has 36 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 pending, 20 abandoned, 5 cancelled.
What trademark classes does Avenue 81, Inc. file in?
Avenue 81, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Avenue 81, Inc.'s most well-known trademarks?
Avenue 81, Inc.'s registered trademark portfolio includes well-known marks such as DRIP, LEADBOXES, LEADPAGES, and C CONVERTED. These are among 9 currently registered trademarks in the portfolio.
What is Avenue 81, Inc.'s trademark registration success rate?
Avenue 81, Inc. has a 26% trademark registration rate, with 9 out of 34 resolved applications resulting in successful registration. Currently, 2 applications are pending review.